期刊
JOURNAL OF IMMUNOLOGY
卷 180, 期 5, 页码 2757-2761出版社
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.180.5.2757
关键词
-
类别
资金
- NCRR NIH HHS [P41 RR001209-277870, P41 RR001209-286019, P41 RR001209-297996] Funding Source: Medline
The peripheral induction of T regulatory cells can be accomplished by TGF-beta through an epigenetic regulation leading to the expression of Foxp3. However, the exact mechanism of such a TGF-beta-mediated action remains unclear. In the current study, we found that TGF-beta treatment of CD4(+) CD25(-) T cells during T cell activation led to a transient inhibition of the phosphorylation of ERK followed by the induction of Foxp3 expression in these cells. Direct treatment with a specific ERK inhibitor, UO126, during CD4(+) CD25(-) T cell activation also induced Foxp3 expression and conferred a suppressive function to the induced Foxp3(+) T cells. Furthermore, treatment of T cells with either TGF-beta or UO126 significantly down-regulated the expression of DNMTs, a reaction normally elicited by demethylation agents, such as 5-Aza-2'deoxycytidine. These results indicate that the epigenetic regulation of TGF-beta-induced expression of Foxp3 may be mediated through the inactivation of ERK.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据